Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Find us at: Dont gamble with your health
Ipamorelin amplifies each pulse Tesamorelin (Egrifta) Mimics natural GHRH to trigger pituitary GH release Clinical Data CJC-1295/Ipamorelin Phase 2 (CJC-1295), preclinical + Phase 2 (Ipamorelin) Tesamorelin (Egrifta) Two Phase 3 RCTs, 816 patients Approved Indication CJC-1295/Ipamorelin None (compounded) Tesamorelin (Egrifta) HIV-associated lipodystrophy Availability CJC-1295/Ipamorelin Compounding pharmacy with prescription Tesamorelin (Egrifta) Compounding pharmacy with prescription (also as branded Egrifta) PeRx Offers Both PeRx prescribes both CJC-1295/Ipamorelin and Tesamorelin
You can expect to see visible improvements within a few weeks of regular use, although some users notice changes even sooner
However, those drugs are only FDA-approved to treat type 2 diabetes (along with diet and exercise), not obesity
Emerging research suggests that GLP-1 receptor agonists, including semaglutide (sold as Ozempic and Wegovy), may be associated with bone density changes in specific populations, primarily through the mechanism of rapid weight loss rather than a proven direct drug effect on bone tissue
Women with PCOS have a higher risk of developing diabetes
